The State of Texas sued multiple pharmaceutical companies, alleging they engaged in a “conspiracy” to significantly increase prices of insulin for customers.
Attorney General Ken Paxton filed the lawsuit on October 3 against pharmacy benefit managers (PBMs) and insulin manufacturers including CVS Health Corporation, Express Scripts, Eli Lilly and Company, UnitedHealth Group, and others for working “in coordination” to “distort the market for diabetic treatments to their benefit and at the expense of Texas diabetics and payors.”
